LEXX
NASDAQ · Pharmaceuticals
Lexaria Bioscience Corp
$0.57
-0.02 (-2.63%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+4,557.3% upside
Low Target
$20.55
Average Target
$26.43
High Target
$40.48
Current Price
$0.57
Current
$0.57
$0.57
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Scenario Analysis
Bear Case
$20.55
3,521.1%
Low target
Base Case
$26.43
+4,557.3%
Avg target
Bull Case
$40.48
+7,033.0%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$1.55
-63.4% from high
52-Week Low
$0.46
+23.4% from low
Target vs 52W High
$26.43
+1,605.2% vs high
Next Earnings Report
Jul 13, 2026
18d
until earnings
EPS Est: $-0.09
Peer Consensus — Pharmaceuticals